For the first time since its foundation, EIT Health offers the first pan-European crowdfunding platform dedicated exclusively to the healthcare sector. T
Read moreThe biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to start Phase IIb of the clinical trial of the HIPRA vac...
Read moreSe trata de una compañía tecnológica impulsada por el Barcelonaβeta Brain Research Center (BBRC) en conjunto con los investigaodres Dr. Juan Domingo Gispert y Dr. José Luis Molinuevo.
Read moreLa primera aproximación de terapia génica para tratar la leucoencefalopatía megalencefálica con quistes subcorticales (MLC) ha sido designada como medicamento huérfano por la Agencia Europea del ...
Read moreThis morning at the Barcelona Science Park, the first edition of the accelerator kicked off in an event presided by Mayor Ada Colau and University of Barcelona Rector Joan Guàrdia
Read moreIntegra Therapeutics (Integra Tx), a biotechnology company that is creating next-generation gene editing tools to boost the efficiency and safety of advanced therapies, has completed its first roun...
Read moreEl proyecto «Early molecular nanoDIAGnostics of Brain tumors using ImmunePET (DIAGBI)» recibirá más de 1,4 millones de euros de financiación entre 2021 y 2024 dentro de la convocatoria de Proy...
Read moreGracias a los fondos conseguidos por el Grupo de Ingeniería Vascular y Biomedicina Aplicada (GEVAB) en el marco del proyecto CaixaImpulse Consolidate 2020, el Laboratorio de Ingeniería de Productos ...
Read moreNorthSea Therapeutics B.V., (‘NST’) a biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic diseases, today an...
Read moreFinal session of the second Biocat Pitch Training Program with helpful tips for catching investors’ eyes. Take note and put them into practice!
Read moreCon esta operación la Xunta sigue mostrando su compromiso con el sector de la biotecnología, un ámbito para cuyo impulso el Gobierno gallego cuenta con la Estrategia de consolidación del sector bi...
Read moreNorthSea Therapeutics B.V., (‘NST’), a biotech company developing novel and innovative strategies for the treatment of NASH and other metabolic diseases, announces it has initiated a Phase 1 stud...
Read more